Renal after cardiothoracic transplant: The effect of repeat mismatches on outcome

Transplantation

Volumn 87, Issue 11, 2009, Pages 1727-1732

  Caskey, Fergus J ^a   Johnson, Rachel J ^b   Fuggle, Susan V ^c   Start, Samantha ^b   Pugh, Diana ^b   Dudley, Christopher R K ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b UK Transplant   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Renal transplant outcomes; Repeat mismatch; Sequential renal transplant

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEART GRAFT; HISTOINCOMPATIBILITY; HLA MATCHING; HLA SYSTEM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; LIVER GRAFT; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THORAX SURGERY;

ADULT; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HEART-LUNG TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; SURVIVAL RATE; TISSUE DONORS;

EID: 67649598558     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181a60c51     Document Type: Article

References (25)

1. Wilkinson AH, Cohen DJ. Renal failure in the recipients of nonrenal solid organ transplants. J Am Soc Nephrol 1999; 10: 1136.
2. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931.
3. The Organ Procurement Transplantation Network. Policy 3.5, Organ distribution: Allocation of deceased kidneys, vol. 2007. Richmond, VA, OPTN 2007.
4. Harmer A. Guidelines for the detection and characterization of clinically relevant antibodies in solid organ transplantation. UK, British Society for Histocompatibility and Immunogenetics & British Transplantation Society 2004.
5. National Specialist Commissioning Advisory Group. National liver transplant standards. London, UK, The Department of Health 2005.
6. National Specialist Commissioning Advisory Group. National heart and lung transplant standards. London, UK, The Department of Health 2006.
7. The Organ Procurement Transplantation Network. Policy 3.6, Organ distribution: Allocation of livers, vol. 2007. Richmond, VA, OPTN 2006.
8. The Organ Procurement Transplantation Network. Policy 3.7, Organ distribution: Allocation of thoracic organs, vol 2007. Richmond, VA, OPTN 2007.
9. Hourmant M, Cesbron-Gautier A, Terasaki PI, et al. Frequency and clinical implications of development of donor-specific and non-donorspecific HLA antibodies after kidney transplantation. J AmSoc Nephrol2005; 16: 2804.
10. Tambur AR, Pamboukian SV, Costanzo MR, et al. The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome. Transplantation 2005; 80: 1019.
11. Sundaresan S, Mohanakumar T, Smith MA, et al. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation 1998; 65: 648.
12. Cardarelli F, Pascual M, Chung RT, et al. Interferon-alpha therapy in liver transplant recipients: Lack of association with increased production of anti-HLA antibodies. Am J Transplant 2004; 4: 1352.
13. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine. J AmSoc Nephrol2000; 11: 155A.
14. Fuggle SV, Johnson RJ, Rudge CJ, et al. Human leukocyte antigen and the allocation of kidneys from cadaver donors in the United Kingdom. Transplantation 2004; 77: 618.
15. Farney AC, Matas AJ, Noreen HJ, et al. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival? Clin Transplant 1996; 10: 147.
16. Heise ER, Thacker LR, MacQueen JM, et al. Repeated HLA mismatches and second renal graft survival in centers of the South-Eastern Organ Procurement Foundation. Clin Transplant 1996; 10(6 Pt 2): 579.
17. Cecka JM, Terasaki PI. Repeating HLA antigen mismatches in renal retransplants-A second class mistake? Transplantation 1994; 57: 515.
18. Gjertson DW. A multi-factor analysis of kidney regraft outcomes. Clin Transpl 2002: 335.
19. Worthington JE, Martin S, Al-Husseini DM, et al. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Transplantation 2003; 75: 1034.
20. Coopersmith CM, Brennan DC, Miller B, et al. Renal transplantation following previous heart, liver, and lung transplantation: An 8-year single-center experience. Surgery 2001; 130: 457.
21. Kuo PC, Luikart H, Busse-Henry S, et al. Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients. Clin Transplant 1995; 9: 92.
22. Gugenheim J, Amorosa L, Gigou M, et al. Specific absorption of lymphocytotoxic alloantibodies by the liver in inbred rats. Transplantation1990; 50: 309.
23. Davies HS, Pollard SG, Calne RY. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 1989; 47: 524.
24. Sumimoto R, Kamada N. Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody. Transplantation 1990; 50: 678.
25. Simpson N, Cho YW, Cicciarelli JC, et al. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: Analysis of UNOS Database. Transplantation 2006; 82: 1298.